{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:56:14Z","timestamp":1791453374478,"version":"4.3.3"},"reference-count":81,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA272883"],"award-info":[{"award-number":["R37CA272883"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clml.2025.05.023","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T20:33:35Z","timestamp":1748723615000},"page":"e696-e703.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monoclonal Gammopathies in Africa"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-1954","authenticated-orcid":false,"given":"Abiola","family":"Bolarinwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lateef","family":"Odukoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Buadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Vachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Paemka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B","family":"Baughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joselle M","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clml.2025.05.023_bib0001","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1445-5994.1992.tb02127.x","article-title":"Current concepts on monoclonal gammopathies","volume":"22","author":"Kyle","year":"1992","journal-title":"Aust N Z J Med"},{"issue":"11 Pt 2","key":"10.1016\/j.clml.2025.05.023_bib0002","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/clinchem\/40.11.2154","article-title":"The monoclonal gammopathies","volume":"40","author":"Kyle","year":"1994","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.clml.2025.05.023_bib0003","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41408-018-0132-1","article-title":"Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry","volume":"8","author":"Baughn","year":"2018","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.clml.2025.05.023_bib0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-020-0284-7","article-title":"Dissecting racial disparities in multiple myeloma","volume":"10","author":"Marinac","year":"2020","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.clml.2025.05.023_bib0005","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/molbev\/msaa033","article-title":"Origins, Admixture Dynamics, and Homogenization of the African Gene Pool in the Americas","volume":"37","author":"Gouveia","year":"2020","journal-title":"Mol Biol Evol"},{"issue":"25","key":"10.1016\/j.clml.2025.05.023_bib0006","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clml.2025.05.023_bib0007","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1038\/bcj.2017.97","article-title":"Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey","volume":"7","author":"Landgren","year":"2017","journal-title":"Blood Cancer J"},{"issue":"16","key":"10.1016\/j.clml.2025.05.023_bib0008","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2012-07-443606","article-title":"Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach","volume":"121","author":"Baker","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0009","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1038\/bcj.2014.91","article-title":"Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study","volume":"5","author":"Greenberg","year":"2015","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.clml.2025.05.023_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-019-0177-9","article-title":"Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients","volume":"9","author":"Kazandjian","year":"2019","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/genetics\/161.1.269","article-title":"Larger genetic differences within africans than between Africans and Eurasians","volume":"161","author":"Yu","year":"2002","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0012","first-page":"1","article-title":"60,000 years of interactions between Central and Eastern Africa documented by major African mitochondrial haplogroup L2","volume":"5","author":"Silva","year":"2015","journal-title":"OriginalPaper. Sci Rep."},{"issue":"12","key":"10.1016\/j.clml.2025.05.023_bib0013","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41431-019-0466-6","article-title":"Genetic relationships of European, Mediterranean, and SW Asian populations using a panel of 55 AISNPs","volume":"27","author":"Pakstis","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clml.2025.05.023_bib0014","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.genom.9.081307.164258","article-title":"African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping","volume":"9","author":"Campbell","year":"2008","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.clml.2025.05.023_bib0015","unstructured":"U.S. Census changes how it identifies people by race and ethnicity, creates Middle Eastern category for first time. https:\/\/www.pbs.org\/newshour\/politics\/u-s-census-changes-how-it-identifies-people-by-race-and-ethnicity-creates-middle-eastern-and-north-african-category-for-first-time. (Accessed December 10, 2024)."},{"issue":"12","key":"10.1016\/j.clml.2025.05.023_bib0016","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.clml.2025.05.023_bib0017","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.clml.2025.05.023_bib0018","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/1055-9965.EPI-22-0525","article-title":"Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men","volume":"31","author":"Cicero","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clml.2025.05.023_bib0019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2326-12-7","article-title":"Prevalence and type of monoclonal gammopathy of undetermined significance in an apparently healthy Nigerian population: a cross sectional study","volume":"12","author":"Onwah","year":"2012","journal-title":"BMC Blood Disord"},{"issue":"4","key":"10.1016\/j.clml.2025.05.023_bib0020","first-page":"311","article-title":"Homogeneous immunoglobulins in Ghanaians living in Accra, Ghana","volume":"33","author":"Oyeyinka","year":"2004","journal-title":"Afr J Med Med Sci"},{"issue":"4","key":"10.1016\/j.clml.2025.05.023_bib0021","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkae056","article-title":"Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa","volume":"8","author":"Cicero","year":"2024","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1016\/j.clml.2025.05.023_bib0022","article-title":"Serum free light chains in a racially diverse population including African Americans and populations from South Africa","author":"Bertamini","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.clml.2025.05.023_bib0023","series-title":"GLOBOCAN 2022 (version 1.1): Cancer Today","year":"2024"},{"issue":"9","key":"10.1016\/j.clml.2025.05.023_bib0024","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2025.05.023_bib0025","series-title":"Cancer in Sub-Saharan Africa","author":"Parkin","year":"2018"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0026","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4314\/gmj.v53i1.8","article-title":"Presentation and survival of multiple myeloma patients in Ghana: a review of 169 cases","volume":"53","author":"Acquah","year":"2019","journal-title":"Ghana Med J"},{"key":"10.1016\/j.clml.2025.05.023_bib0027","first-page":"262","article-title":"Diagnostic and evolutionary profile of multiple myeloma in Senegal: monocentric study conducted from 2005 to 2016]","volume":"27","author":"Fall","year":"2017","journal-title":"Pan Afr Med J"},{"issue":"3","key":"10.1016\/j.clml.2025.05.023_bib0028","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/10428190902741471","article-title":"Diagnostic delay and complications for older adults with multiple myeloma","volume":"50","author":"Friese","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2025.05.023_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/3208717","article-title":"Clinical Profile and Treatment of Multiple Myeloma at a Tertiary Hospital in Kenya: A Five-Year Retrospective Review","volume":"2024","author":"Gichuru","year":"2024","journal-title":"Adv Hematol"},{"key":"10.1016\/j.clml.2025.05.023_bib0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.11604\/pamj.2015.22.292.7774","article-title":"Multiple myeloma in Nigeria: a multi-centre epidemiological and biomedical study","volume":"22","author":"Nnonyelum","year":"2015","journal-title":"Pan Afr Med J"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0031","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.clml.2025.05.023_bib0032","first-page":"e4716","article-title":"Laboratory Features of Newly Diagnosed Multiple Myeloma Patients","volume":"11","author":"Hussain","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0033","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4314\/ahs.v21i1.11","article-title":"Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute","volume":"21","author":"Okello","year":"2021","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.clml.2025.05.023_bib0034","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1200\/GO.20.00573","article-title":"Retrospective Analysis of Presentation, Treatment, and Outcomes of Multiple Myeloma at a Large Public Referral Hospital in Eldoret","volume":"7","author":"Manyega","year":"2021","journal-title":"Kenya. JCO Glob Oncol."},{"issue":"5-6","key":"10.1016\/j.clml.2025.05.023_bib0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10428199809057562","article-title":"Multiple myeloma in young patients: clinical presentation and treatment approach","volume":"30","author":"Blade","year":"1998","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.clml.2025.05.023_bib0036","doi-asserted-by":"crossref","first-page":"IJH27","DOI":"10.2217\/ijh-2020-0003","article-title":"Globulin fraction and albumin: globulin ratio as a predictor of mortality in a South African multiple myeloma cohort","volume":"9","author":"Laudin","year":"2020","journal-title":"Int J Hematol Oncol"},{"issue":"10","key":"10.1016\/j.clml.2025.05.023_bib0037","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1016\/S2352-3026(21)00198-8","article-title":"Haematological malignancies in sub-Saharan Africa: east Africa as an example for improving care","volume":"8","author":"Okello","year":"2021","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.clml.2025.05.023_bib0038","first-page":"415","article-title":"Epidemiological, clinical and pronostic aspects of multiple myeloma eligible for therapeutic intensification followed by autologous hematopoietic stem cell in the Algerian West: report of 147 cases","volume":"95","author":"Mohammadi","year":"2017","journal-title":"Tunis Med"},{"issue":"2","key":"10.1016\/j.clml.2025.05.023_bib0039","first-page":"67","article-title":"Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria","volume":"68","author":"Belouni","year":"2020","journal-title":"Curr Res Transl Med"},{"issue":"4","key":"10.1016\/j.clml.2025.05.023_bib0040","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1016\/j.clml.2020.11.013","article-title":"Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data","volume":"21","author":"Kaur","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"10.1016\/j.clml.2025.05.023_bib0041","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7196\/SAMJ.2017.v107i9.12360","article-title":"Concomitant HIV infection in newly diagnosed multiple myeloma patients is hard to recognise and should be tested for routinely in areas of high endemicity","volume":"107","author":"De Groot","year":"2017","journal-title":"S Afr Med J"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0042","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s43046-020-00054-0","article-title":"The clinical impact of hepatitis C virus infection in Egyptian multiple myeloma patients","volume":"32","author":"Kassem","year":"2020","journal-title":"J Egypt Natl Canc Inst"},{"issue":"10","key":"10.1016\/j.clml.2025.05.023_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287304","article-title":"Profile and outcome of multiple myeloma with and without HIV treated at a tertiary hospital in KwaZulu-Natal, South Africa","volume":"18","author":"Chili","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2025.05.023_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1177775","article-title":"Immunophenotypic expression profile of multiple myeloma cases at a tertiary hospital in Nairobi Kenya","volume":"10","author":"Mengich","year":"2023","journal-title":"Frontiers in Medicine"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4102\/ajlm.v10i1.1713","article-title":"Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker","volume":"10","author":"Zahran","year":"2021","journal-title":"Afr J Lab Med"},{"issue":"6","key":"10.1016\/j.clml.2025.05.023_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061454","article-title":"Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma","volume":"13","author":"Damasceno","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clml.2025.05.023_bib0047","first-page":"117","article-title":"The Frequency and clinical Implications of Lymphocyte Subsets and Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma Patients","volume":"26","author":"Zahran","year":"2019","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.clml.2025.05.023_bib0048","first-page":"1","article-title":"Lymphocyte profile in peripheral blood of patients with multiple myeloma","author":"Dekojov\u00e1","year":"2024","journal-title":"OriginalPaper. Ann Hematol."},{"issue":"11","key":"10.1016\/j.clml.2025.05.023_bib0049","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.3390\/ijms20112822","article-title":"Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma","volume":"20","author":"Allegra","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.clml.2025.05.023_bib0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/iid3.53","article-title":"The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma","volume":"3","author":"Sponaas","year":"2015","journal-title":"Immunity, Inflammation and Disease."},{"issue":"3","key":"10.1016\/j.clml.2025.05.023_bib0051","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.1992.tb08137.x","article-title":"Lymphoid subsets and prognostic factors in multiple myeloma. Cooperative Group for the Study of Monoclonal Gammopathies","volume":"80","author":"San Miguel","year":"1992","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.clml.2025.05.023_bib0052","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","article-title":"Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma","volume":"1","author":"Zavidij","year":"2020","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0053","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s43042-022-00220-0","article-title":"Clonal heterogeneity by fluorescence in situ hybridization in multiple myeloma: enhanced cytogenetic risk stratification. OriginalPaper","volume":"23","author":"Abdel-Qader","year":"2022","journal-title":"Egypt J Med Hum Genet"},{"issue":"2","key":"10.1016\/j.clml.2025.05.023_bib0054","first-page":"95","article-title":"Detection of chromosome 13 (13q14) deletion among Sudanese patients with multiple myeloma using a molecular genetics fluorescent in situ hybridization technique (FISH)","volume":"37","author":"Dowd","year":"2015","journal-title":"Malaysian Journal of Pathology"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000334878","article-title":"Molecular cytogenetic aberrations in Tunisian patients with multiple myeloma identified by cIg-FISH in fixed bone marrow cells","volume":"136","author":"Gmidene","year":"2012","journal-title":"Cytogenet Genome Res"},{"issue":"9","key":"10.1016\/j.clml.2025.05.023_bib0056","doi-asserted-by":"crossref","first-page":"e1363","DOI":"10.1002\/mgg3.1363","article-title":"Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients","volume":"8","author":"Hamdaoui","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"8","key":"10.1016\/j.clml.2025.05.023_bib0057","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-020-00348-5","article-title":"Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response","volume":"10","author":"Abdallah","year":"2020","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0058","first-page":"1","article-title":"Are African primary physicians suspicious enough? Challenges of multiple myeloma diagnosis in Africa","volume":"33","author":"Thokerunga","year":"2021","journal-title":"ReviewPaper. The Egyptian Journal of Internal Medicine"},{"issue":"4","key":"10.1016\/j.clml.2025.05.023_bib0059","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/blood.2024024371","article-title":"EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma","volume":"144","author":"Landgren","year":"2024","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clml.2025.05.023_bib0060","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/cncr.31237","article-title":"Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities","volume":"124","author":"Ailawadhi","year":"2018","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clml.2025.05.023_bib0061","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00277-023-05221-6","article-title":"The presence of two light chain bands on immunofixation is associated with poor outcomes in newly diagnosed multiple myeloma patients","volume":"102","author":"Jerbi","year":"2023","journal-title":"Ann Hematol"},{"issue":"0","key":"10.1016\/j.clml.2025.05.023_bib0062","article-title":"Comparison of Laboratory Data at Initial Diagnosis of Multiple Myeloma Between Black Africans, African Americans and White patients","volume":"0","author":"Essiaw","year":"2024","journal-title":"Clinical Lymphoma, Myeloma and Leukemia."},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0063","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2023.2261803","article-title":"Description of multiple myeloma cases and assessment of survival and mortality factors in Madagascar","volume":"28","author":"Randrianarisoa","year":"2023","journal-title":"Hematology"},{"issue":"6","key":"10.1016\/j.clml.2025.05.023_bib0064","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1182\/bloodadvances.2021005482","article-title":"Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials","volume":"6","author":"Kanapuru","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2025.05.023_bib0065","first-page":"105","article-title":"Multiple myeloma and autologous haematopoietic stem-cell transplantation without cryopreservation: experiences of the Clinical Hematology Department of Casablanca, Morocco]","volume":"39","author":"Fares","year":"2021","journal-title":"Pan Afr Med J"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0066","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12882-019-1601-x","article-title":"Pattern of renal amyloidosis in South Africa","volume":"20","author":"Hassen","year":"2019","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.clml.2025.05.023_bib0067","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4103\/1319-2442.385967","article-title":"The Clinical Features and Outcomes of Renal Amyloidosis in Tunisia","volume":"33","author":"Ayed","year":"2022","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"8","key":"10.1016\/j.clml.2025.05.023_bib0068","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.canrad.2019.06.013","article-title":"[Solitary bone plasmocytoma: Experience from the radiotherapy department at Mohammed-V military teaching hospital in Rabat (Morocco)]","volume":"23","author":"Hadadi","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.clml.2025.05.023_bib0069","article-title":"Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies","volume":"8","author":"Fatoki","year":"2022","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.clml.2025.05.023_bib0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/GO.20.00572","article-title":"Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya","volume":"7","author":"Oduor","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.clml.2025.05.023_bib0071","unstructured":"African Development Bank Group (AfDB). Strategy for Quality Health Infrastructure in Africa 2022\u20132030. Published February 2022. https:\/\/www.afdb.org\/sites\/default\/files\/documents\/publications\/strategy_for_quality_health_infrastructure_in_africa_2022-2030.pdf (Accessed January 2, 2025.)"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0072","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-17842-1","article-title":"Barriers to cervical cancer screening in Africa: a systematic review","volume":"24","author":"Mantula","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clml.2025.05.023_bib0073","unstructured":"IMF. International Myeloma Foundation (IMF) Launches M-Power New York to Improve Multiple Myeloma Outcomes in the Black Community. https:\/\/www.myeloma.org\/news-events\/multiple-myeloma-news\/imf-launches-m-power-ny-improve-multiple-myeloma-outcomesfiles\/531\/imf-launches-m-power-ny-improve-multiple-myeloma-outcomes.html Accessed 07-01-2024, 2024"},{"issue":"7","key":"10.1016\/j.clml.2025.05.023_bib0074","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0075","first-page":"81","article-title":"Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features","volume":"27","author":"VanValkenburg","year":"2016","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.clml.2025.05.023_bib0076","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2019000491","article-title":"A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry","volume":"4","author":"Du","year":"2020","journal-title":"Blood Adv"},{"issue":"Pt 4","key":"10.1016\/j.clml.2025.05.023_bib0077","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1258\/acb.2010.010003","article-title":"Germishuys JJ. Monoclonal gammopathy and other serum protein electrophoresis patterns in patients with HIV infection in South Africa","volume":"47","author":"van Vuuren","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.clml.2025.05.023_bib0078","unstructured":"World Health Organization, Regional Office for Africa (WHO AFRO). HIV\/AIDS Tracker. https:\/\/aho.afro.who.int\/trackers\/af?tr=hiv&des=HIV%20\/%20AIDS. (Accessed April 14, 2024)."},{"key":"10.1016\/j.clml.2025.05.023_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.876271","article-title":"Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance","volume":"13","author":"Sigurbergsdottir","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.clml.2025.05.023_bib0080","unstructured":"World Health Organization Regional office for Africa, Integrated African Health Observatory (IAHO). Women's health in the African Region. https:\/\/files.aho.afro.who.int\/afahobckpcontainer\/production\/files\/Womens_Health_Regional_Factsheet.pdf Updated March 2023. Accessed April 14 2024."},{"issue":"7","key":"10.1016\/j.clml.2025.05.023_bib0081","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008524","article-title":"Genetic variation and adaptation in Africa: implications for human evolution and disease","volume":"6","author":"Gomez","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T03:21:31Z","timestamp":1755746491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2152265025001995"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.05.023","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal Gammopathies in Africa","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}